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Abstract
Purpose Surgical series of pineal region gliomas are rarely available. Whereas it is a general assumption that the extent of 
surgical resection correlates with survival outcomes of intracranial gliomas; the impact of the microsurgical resection on 
the long-term outcomes of pineal gliomas has been questioned. We present a surgical series of pineal region gliomas with 
focus on the survival outcome analysis.
Methods 17 histologically confirmed pineal region glioma patients classified as diffuse and non-diffuse gliomas were retro-
spectively analyzed. A detailed description of the series was followed by regression models to identify predictors of clinical 
outcomes. Uni- a multivariate survival analysis was performed to determine independent predictors of mortality.
Results Although the number of treated patients was small, only WHO grade histopathology remained significant (p = 0.02) 
after multivariate survival analysis with extent of resection, age, tumor volume, and preoperative functional status. The 
extent of the surgical resection did not correlate with the disease survival rates of non-diffuse (p = 1), diffuse (p = 0.2), nor 
all gliomas (p = 0.6). 15 of 17 patients underwent gross total (nine patients) or subtotal resection. The preoperative functional 
status of the patients showed overall improvement on the immediate (p < 0.001) and long-term (p = 0.03) follow-up after 
106 (3 – 324) months.
Conclusion The extent of the surgical resection does not seem to significantly impact on the survival outcomes of pineal 
region gliomas. Thus, genotype and molecular features may essentially affect the outcome. Further research on the field is 
required.
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Introduction
Pineal region tumors represent around one percent of all 
intracranial neoplasms in the general population, and glio-
mas represent about 10% to 38% of pineal region tumors 
[1–8]. Gliomas are classified as diffuse and nondiffuse 
gliomas, and the recent 2016 World Health Organization 
(WHO) classification of tumors of the Central Nervous Sys-
tem (CNS) employed for the first time molecular features 
to subdivide gliomas, especially the diffuse ones [9, 10]. 
Pineal region gliomas originate from the pineal gland tissue 
or from the surrounding structures. Surgical series specifi-
cally dealing with pineal region gliomas are almost absent in 
the literature [7, 8]. Whereas it is a general assumption that 
the extent of surgical resection correlates with survival out-
comes of intracranial gliomas; the impact of the microsurgi-
cal resection on the long-term outcomes of pineal gliomas 
has been questioned [8].
Our previous publication on the management of pineal 
region tumors reported an overall high correlation between 
a complete microsurgical resection and better survival out-
comes [1]. Here, we aim to present and analyze the survival 
outcomes of the surgically treated pineal region gliomas in 




This project has been approved by the Ethics Committee of 
HUH. This is a retrospective study of all consecutive his-
tologically confirmed gliomas operated in HUH, between 
1997 and 2015. Pre- and postoperative functional status 
measured by the modified Rankin Scale (mRS), and all 
the therapeutic modalities for the treatment were retrieved 
from hospital records. Radiological information of the glio-
mas was acquired from IMPAX 6.7.0.4511 (Agfa, Mortsel, 
Belgium). Final status of the patients was analyzed in July 
2018. The extent of the surgical resection of the tumors was 
evaluated in the postoperative magnetic resonance imaging 
(MRI) studies. The term gross total resection (GTR) refers 
to the absence of any residual lesion in the postoperative 
T1WI, T2WI, or FLAIR MRI sequences. Subtotal resec-
tion (STR) means just a small residual lesion usually very 
attached to the neurovascular structures; and partial resec-
tion (PR) represents less than 95% of tumor removal. The 
American Academy of Pediatrics recommends 21 year-
old as the upper age limit for the evaluation of pediatric 
patients [11, 12]. However, based on the distribution of our 
study population, we classified the patients as 5-year-old or 
younger and 20-year-old or older patients.
Analysis of the data
R programming environment (© R Core Team, Boston, 
USA) was used for statistical analysis. We performed a gen-
eral description of the study population categorized into 2 
groups: the low-grade I-II nondiffuse glioma and the high-
grade diffuse grade II-IV glioma groups. Initial uni- and 
bivariate analysis of the data was performed for identifica-
tion of factors predicting clinical outcome. Fisher, Wilcoxon, 
or Spearman correlation tests were utilized wherever appro-
priate. Univariate survival analysis related with the diagno-
sis and with the extent of resection was performed by the 
likelihood ratio Cox model. The multifactorial survival anal-
ysis was determined by Cox survival model. The raw p-value 
cutoff for significance in all tests was set at 0.05. Adjustment 
of the p-value was performed with Benjamini–Hochberg 
procedure (α = 0.1).
Results
Of the 76 surgically treated pineal region tumors, 18 gli-
oma patients were operated during the study period. One 
patient with the histological diagnosis of gliosis/glioma was 
excluded from the analysis. A pilocytic astrocytoma (PA) 
patient was initially treated with biopsy and radiotherapy 
in 1985, followed by brachytherapy in 1995, and surgical 
removal in 2000. 17 patients (13 males) met the inclusion 
criteria: 10 nondiffuse grade I PA patients; two nondiffuse 
grade I-II ependymomas, and five diffuse (one WHO grade 
II, two WHO grade III, and two WHO grade IV) astrocytic 
gliomas. All of them underwent evaluation at the last follow-
up (FU). All patients underwent surgery in praying sitting 
position by the senior author JH [13, 14]. Adjuvant radio-
chemotherapy protocols are detailed in Table 1.
Preoperative presentation and surgical features
The comparative analysis between the diffuse and nondiffuse 
gliomas is presented in Table 2. The clinical presentation of 
the patients was related with acute or progressive hydroceph-
alus symptoms (88%), visual and ocular detriment (41%), 
memory disturbances (24%), and motor deficits (12%). 
Detailed information of the patients is attached as appendix 
of this paper. The supracerebellar infratentorial approach 
was used in most of the patients. However, other approaches 
complemented multiple surgeries in two giant-PA patients. 
Around 50% of the patients underwent preliminary shunt 
for the treatment of hydrocephalus. An average of two addi-
tional shunt-related procedures per patient were observed in 
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these patients. Two PA patients had five and 10 shunt-related 
surgeries. Some procedural complications were present in 
two patients of the diffuse glioma group (shunt infection, 
infarction and pneumocephalus); and in 5 patients of the 
Table 1  Adjuvant radiochemotherapy protocols for gliomas at HUH. Number of patients in parenthesis
* Unspecified in the patient records
Adjuvant radiochemotherapy
Pilocytic astrocytoma (10) A giant tumor was initially treated with biopsy and radiotherapy in 1985, followed by brachytherapy in 1995, and 
multiple surgeries since 2000. The patient died 324 months after initial treatment. No other patient received 
adjuvant therapy.
Grade I-II Ependymoma (2) 54 Gy (1.8 Gy/dia) after subtotal resection in one case.
Grade II Astrocytoma (1) None, patient with complications died 3 months after complete resection.
Grade III Astrocytoma (2) 20 Gy (10 Gy/dose) of stereotactic radiosurgery and unspecified chemotherapy* for a small 5 mm local recur-
rence of the tumor, 15 months after subtotal resection (initially suspected as totally resected tumor). The patient 
died 52 months after initial treatment.
Fractionated radiation therapy* and temozolamide 150 mg/m2 (unspecified number of cycles) after partial resec-
tion of the tumor. The patient died 12 months after initial treatment.
Glioblastoma multiforme (2) 54 Gy (1.8 Gy/dia) and temozolomide 150 mg/m2 (2 cycles) after subtotal resection of the tumor. More cycles 
of temozolamide were planned; however, the tumor progressed rapidly. The patient died 5 months after initial 
treatment.
36 Gy (3 Gy/dose) and temozolomide 150 mg/m2 (2 cycles) after complete resection of the tumor. More cycles 
of temozolamide were planned; however, the patient developed a pneumocystis infection and Eaton-Lambert 
syndrome. The patient died 9 months after initial treatment.
Table 2  Comparative analysis between the non diffuse glioma and diffuse glioma patients. For numeric variables, median (interquartile range)
Values with statistical significance in bold
ETV external third ventriculostomy, GTR gross total resection mRS modified Rankin scale, PR partial resection, OTT occipital transtentorial 
approach, SCIT supracerebellar infratentorial approach, STR subtotal resection
All N:17 Nondiffuse Glioma N:12 Diffuse Glioma N:5 P value Adjusted p-value
Age in years 26 (20–51) 23 (4–33) 26 (21–64) 0.56 1
Sex: males 13 (76%) 9 (75%) 4 (80%) 1 1
Preoperative mRS (patients) 2 (1), 3 (3), 4 (7), 5 (6) 2 (1), 3 (2), 4 (5), 5 (4) 3 (1), 4 (2), 5 (2) 0.79 1
Hydrocephalus 15 (88%) 11 (92%) 4 (80%) 0.52 1
Preliminary shunt 8 (53%) 5 (45%) 3 (75%)
Direct surgery 6 (40%) 5 (45%) 1 (25%)
ETV 1 (7%) 1 (9%) 0
Tumor size in mm
 Anterior–posterior 30 (25–38) 29 (26–55) 26 (21–35) 0.40 1
 Cranio-caudal 22 (19–30) 26 (20–33) 20 (19–26) 0.64 0.9
 Axial-wide 25 (22–36) 39 (25–50) 22 (22–36) 0.53 1
Surgical approach 1 1
 SCIT 16 (94%) 11 (92%) 5 (100%)
 OTT 1 (6%) 1 (8%) 0
Extent of resection
 GTR 9 (53%) 7 (58%) 2 (40%) 0.62 1
 STR 6 (35%) 4 (33%) 2 (40%) 1 1
 PR 2 (12%) 1 (8%) 1 (20%) 0.52 1
 Immediate mRS (patients) 1 (4), 2 (6), 3 (4), 4 (3) 1 (3), 2 (4), 3 (4), 4 (1) 1 (1), 2 (2), 4 (2) 0.68 0.9
 Follow-up in months 83 (52–148) 139 (136–231) 9 (5–12) 0.002 0.011
 5-year survival 33% 100% 0  < 0.001 0.005
 10-year survival 39% 100% 0  < 0.001 0.006
 Final mRS (patients) 0 (3), 1 (6), 2 (1), 3 (1), 6 (6) 0 (3), 1 (6), 2 (1), 3 (1), 6 (1) 6 (5) 0.004 0.016
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nondiffuse glioma group (wound infections, meningitis, and 
pneumocephalus).
The postoperative follow up
The immediate postoperative evaluation showed a three-
year-old WHO grade II glioma patient with poor neurologi-
cal response after surgery due to tension pneumocephalus 
that required surgical decompression. Two diffuse glioma 
patients showed a new Parinaud´s syndrome and new dou-
ble vision, respectively. Other two diffuse glioma patients 
did not present new neurological deficits. The immediate 
evaluation of the non-diffuse gliomas revealed four patients 
with new postoperative disfunctions (Parinaud´s syndrome, 
double vision with mild hemiparesis, and two patients with 
only new mild hemiparesis). At the last clinical evaluation, 
the diffuse glioma patients deteriorated progressively and 
died. One PA patient who underwent multiple surgeries har-
bored eye movement disorder associated with postoperative 
epilepsy controlled by medication. Another two-year-old PA 
patient who underwent primary radiotherapy and brachy-
therapy developed psychomotor developmental delay, right 
hand ataxia, and multiple meningiomas. The patient died 
27 years after initial treatment with multiple surgeries for 
the tumor, for the shunt disfunctions, and for the treatment 
of the meningiomas. One patient had walking limitations 
after hip surgery unrelated with the neurosurgical procedure. 
All the other nine non-diffuse glioma patients harbored very 
minimal symptoms such as slight double vision (2 cases), 
sporadic headache (4 cases), or did not report symptoms (3 
cases).
Two cases had early death within six months after sur-
gery. The WHO grade II glioma patient died three months 
after surgery with an extensive delayed postoperative infarc-
tion in the territory of both posterior cerebral arteries. The 
patient underwent complete microsurgical resection of a 
large lesion (35 × 26 × 38 mm). The immediate postopera-
tive imaging did not show signs of ischemia, but tension 
pneumocephalus that required neurosurgical decompression. 
The patient remained stable but with poor functional status. 
Two days later, MRI studies showed signs of infarction that 
increased in size for the following imaging. Another patient 
with a GBM that underwent a subtotal resection presented a 
rapid recurrence of the small lesion with diencephalic com-
promise in the MRI studies and died 5 months after surgery.
Pre and postoperative functional status evaluation
The quantitative evaluation of the pre- and postopera-
tive functional status of the patients demonstrated overall 
improvement at the immediate postoperative mRS meas-
ured at hospital discharge of the patient (Wilcoxon test, 
p = 0.0008) and last clinical FU (Wilcoxon test, p = 0.03) 
(Fig. 1). One patient with a mRS-2 at the last clinical evalu-
ation underwent hip surgery before glioma diagnosis. The 
tumor size did not associate a strong correlation with the 
preoperative (Spearman test, R = -0.25, p = 0.34) nor post-
operative (Spearman test, R = 0.15, p = 0.8) functional status 
of the patients.
Mortality and extent of resection
The overall mortality, similar to the disease-related mor-
tality of this series, was established as 35.3% at a median 
(interquartile range) FU of 83 (52 – 148) months. The over-
all mortality for nondiffuse low grade gliomas was eight 
percent at a median (interquartile range) FU of 138 (78 
– 175) months with a unique PA patient dead at 324 months 
from the initial treatment. All diffuse grade II-IV glioma 
Fig. 1  Preoperative, immediate (at hospital discharge of the patient), 
and last available postoperative functional status of nondiffuse low 
grade glioma (blue), and diffuse high-grade glioma (red) patients. 
mRS, modified Rankin Scale
Fig. 2  Kaplan–Meier curve comparing survival rates between diffuse 
and non-diffuse gliomas. p < 0.001 in the likelihood ratio Cox model 
(Cox LR). In dashed lines, 0.5 of survival rate
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patients died at a median (interquartile range) FU of 9 (5–12) 
months. The 5-year mortality was 100% for diffuse gliomas 
and 0% for nondiffuse gliomas (Fig. 2).
Although the number of treated patients was small, the 
extent of the surgical resection did not impact on the dis-
ease specific survival rates of nondiffuse (p = 1), diffuse 
(p = 0.2), nor all gliomas (p = 0.6) under the likelihood 
ratio Cox model (Fig. 3). Moreover, the extent of the resec-
tion was similar among the different histological types of 
gliomas, and among the diffuse and nondiffuse gliomas 
(Table 2). Overall, 15 of 17 patients underwent GTR (six 
PA, one ependymoma, one grade II glioma, one grade IV 
glioma) or STR (three PA, one ependymoma, one grade III 
glioma, one grade IV glioma), and only two patients (the 
cystic component of a giant PA, and one grade III glioma) 
underwent PR. On the other hand, the evidence of tumor at 
the last MRI of patients who underwent incomplete resec-
tion was significantly higher than those who underwent GTR 
(Fisher test, p = 0.02). The extent of resection did not cor-
relate with tumor size (Wilcoxon test, p > 0.05). However, 
tumors with median (interquartile range) large diameters of 
30 (23 – 35) mm tended to GTR compared to those with 
median (interquartile range) large diameters of 35 (26 – 44) 
mm that underwent incomplete removal. None of the non-
diffuse gliomas presented progression of the disease after 
surgery. The intracranial progression of the diffuse gliomas 
was as follows: The grade II glioma did not present recur-
rence. The two grade III gliomas presented local recurrences 
without distal recurrences. One grade IV glioma presented 
local recurrence without distal recurrence after subtotal 
resection; and the other grade IV glioma patient did not pre-
sent local recurrence, but multiple foci of distal recurrence 
in the posterior fossa after complete resection of the tumor.
The best predictor of mortality in univariate Cox model 
analysis, the WHO grade of the tumor (p < 0.001), was the 
single significant variable (p = 0.02) after multivariate Cox 
model survival analysis with extent of resection, age, tumor 
volume, and preoperative mRS (Fig. 4). We could not prop-
erly incorporated adjuvant radiochemotherapy for multivari-
ate analysis of mortality since adjuvant radiochemotherapy 
protocols of the gliomas, particularly the diffuse ones, 
widely varied between the patients (Table 1).
Pediatric population
Details of pineal region gliomas in the pediatric population 
are presented in Table 3. Four children under the age of five 
(one female and three males) harbored gliomas (three PA 
and one grade II diffuse glioma) of the pineal region. The 
tumor size in children looked significantly higher compared 
to adults and might be focus of further research.
Discussion
This is a report of the long-term outcomes of 17 surgically 
treated pineal region gliomas in HUH along 20 years of FU. 
Nondiffuse grade I-II gliomas had survival rates of 92%, 
while diffuse grade II-IV gliomas had 100% mortality along 
the FU. Differences in the extent of resection between GTR 
and incomplete resection -mostly represented by the STR- 
were not observed to consistently affect the survival out-
comes of pineal region gliomas.
Tumors of the pineal region represent around one per-
cent of all intracranial neoplasms with higher incidences 
in Northeast Asia. The distribution of pineal region tumors 
also widely vary between different populations with highly 
prevalent germ cell tumors in some Asia countries and pin-
eal parenchymal tumors in some European countries [1, 3, 
15–20]. Gliomas of the pineal region represent between 10 
and 38% of the lesions [1–8]. According to the comprehen-
sive review of Magrini et al., diffuse grade II astrocytomas 
are the most frequent subtype of tumor with 25% of the 
lesions, followed by glioblastoma with 19% of them [7, 8]. 
Fig. 3  Kaplan–Meier curve for the analysis of extent of surgical 
resection and survival rates of pineal region gliomas; GTR, gross 
total resection. p = 0.6 in the likelihood ratio Cox model (Cox LR). In 
dashed lines, 0.5 of survival rate
Fig. 4  Multivariate Cox model analysis for the mortality of pineal 
region glioma patients. GTR, gross total resection; mRS1, preopera-
tive modified Rankin scale; WHO_Grade, World Health Organization 
grade diagnosis
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In this series, PA (59%) were the most frequent gliomas of 
the pineal region.
Gliomas of the CNS comprise two main groups, dif-
fuse and nondiffuse tumors. The 2016 WHO classification 
of tumors of the CNS incorporated molecular features to 
subdivide gliomas. Diffuse WHO grade II-IV gliomas cur-
rently include genetic subgroups, such as diffuse glioma 
IDH-mutant 1p/19q codeleted, diffuse glioma IDH-mutant 
1p/19q non-codeleted, and diffuse glioma IDH wildtype. 
Diffuse midline glioma, H3 K27M-mutant was also included 
in the last classification as a new entity with very poor prog-
nosis. Moreover, other molecular features such as the TERT 
promoter mutation, the ATRX mutation, and TP53 among 
others, reorganized even more the diffuse gliomas. In regard 
to nondiffuse gliomas, PAs and ependymomas comprise the 
vast majority of them. Single abnormalities of the mitogen-
activated protein kinase pathway are almost always pre-
sent in PAs, revealing a possible single pathway disease. 
RELA fusion-positive ependymomas are very aggressive 
supratentorial tumors compared to the more benign grade I 
or grade II ependymomas [9].
While clear differences in the survival rates between low 
and high grade gliomas of the CNS are widely published [9, 
10], some discrepancies still exist regarding the survival out-
come of diffuse grade II astrocytomas of the pineal region. 
Even though several publications on the surgical manage-
ment of pineal region tumors analyze gliomas together with 
other types of tumors, large series specifically dealing with 
pineal region gliomas are almost absent in the literature [7, 
8]. A recent publication by Li et al. compared survival rates 
of low (WHO grade I and II) and high grade gliomas (WHO 
grade III and IV) of the pineal region. The mean survival 
rate of low grade gliomas (46% at a FU of 12.5 ± 11 months) 
contrasted with the mean survival rate of high grade glio-
mas (16% at a FU of 36 ± 23 months) [8]. The two diffuse 
grade II astrocytomas presented in that report were alive at 
2 and 24 months of FU. On the other hand, the extensive 
review performed by Magrini et al. found that diffuse grade 
Table 3  Characteristics of the pineal region glioma in children. For numeric variables, median (interquartile range)
Values with statistical significance in bold
ETV external third ventriculostomy, GTR gross total resection, mRS modified Rankin scale, PR partial resection, OTT occipital transtentorial 
approach, SCIT supracerebellar infratentorial approach, STR subtotal resection
All N:17  ≥ 20-year old N:13  ≤ 5-year old N:4 P value Adjusted p-value
Age in years 26 (20–51) 33 (23–54) 2.5 (2 – 3.3)
Sex: males 13 (76%) 10 (77%) 3 (75%) 1 1
Preoperative mRS (patients) 2 (1), 3 (3), 4 (7), 5 (6) 2 (1), 3 (2), 4 (5), 5 (5) 3 (1), 4 (2), 5 (1) 0.79 1
Hydrocephalus 15 (88%) 11 (85%) 4 (100%) 1 1
Preliminary shunt 8 (53%) 5 (39%) 3 (75%)
Direct surgery 6 (40%) 5 (39%) 1 (25%)
ETV 1 (7%) 1 (8%) 0
Diagnosis 1 1
 Non diffuse glioma 12 (71%) 9 (70%) 3 (75%)
 Diffuse glioma 5 (29%) 4 (31%) 1 (25%)
Tumor size in mm
 Anterior–posterior 30 (25–38) 26 (23–30) 47 (37–64) 0.006 0.048
 Cranio-caudal 22 (19–30) 20 (18–28) 31 (26–37) 0.06 0.32
 Axial-wide 25 (22–36) 25 (22–30) 44 (37–51) 0.003 0.048
Surgical approach 1 1
 SCIT 16 (94%) 12 (92%) 4 (100%)
 OTT 1 (6%) 1 (8%) 0
Extent of resection
 GTR 9 (53%) 7 (54%) 2 (50%) 1 1
 STR 6 (35%) 5 (39%) 1 (25%) 1 1
 PR 2 (12%) 1 (8%) 1 (25%) 0.43 1
 Immediate mRS (patients) 1 (4), 2 (6), 3 (4), 4 (3) 1 (4), 2 (5), 3 (2), 4 (2) 2 (1), 3 (2), 4 (1) 0.16 0.64
 Follow-up in months 83 (52–148) 83 (52 – 148) 96 (40–185) 0.96 1
 Tumor at the last MRI 47% 46% 50% 1 1
 Overall mortality 35% 31% 50% 0.58 1
 Final mRS (patients) 0 (3), 1 (6), 2 (1), 3 (1), 6 (6) 0 (2), 1 (6), 2 (1), 6 (4) 0 (1), 3 (1), 6 (2) 0.55 1
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II astrocytomas of the pineal region have dismal differences 
in survival rates compared to the hemispheric counterpart, 
and recommended to classify gliomas of the pineal region 
in pilocytic and non-pilocytic gliomas [7]. In their series the 
two diffuse grade II astrocytomas died 1 and 12 months after 
partial resection and biopsy, respectively. In their words, 
the limited surgical resection of an infiltrative tumor placed 
in a deep surgical area seems to be a very important factor. 
Moreover, pineal gliomas could present molecular features 
of a diffuse midline glioma, H3 K27M-mutant, with very 
poor prognosis [21, 22].
The impact of the extent of the surgical resection in the 
long-term outcome of pineal region gliomas is not well 
established in the literature. Konovalov reported that the 
extent of resection was directly associated with survival rates 
of almost all types of malignant tumors of the pineal region 
[3]. However, even though this assumption could be right for 
pineal parenchymal tumors and non germinomatous germ 
cell tumors, diffuse high grade gliomas may not necessar-
ily follow this tendency [1, 23]. Li et al. published a series 
of 25 cases of pineal region gliomas where differences in 
the survival outcome between tumors undergoing GTR and 
incomplete resection were not statistically significant [8].
Our previous report on the extension of surgical resec-
tion and the outcome of pineal region tumors gave as some 
clues about the reduced impact of the complete microsurgi-
cal resection of diffuse gliomas [1]. In this series moreo-
ver, we confirm that differences in the extent of resection 
did not consistently affect the survival outcomes of PAs 
nor low grade ependymomas. The long-term FU of the 
nondiffuse low grade gliomas discovered only one death 
of twelve patients at a median (interquartile range) FU of 
138 (78 – 175) months, with five (42%) of them undergoing 
incomplete resection. The unique dead patient underwent 
partial resection with persistence of a cystic component after 
multiple surgeries for a giant 9 cm tumor. This patient died 
324 months after initial radiotherapy and brachytherapy. One 
STR ependymoma patient received adjuvant radiotherapy 
with complete control of the tumor. Other three PA patients 
underwent STR without adjuvant therapy and remained sta-
ble along the follow up.
Obviously, the optimal surgical treatment of benign glio-
mas is represented by a complete removal of the lesions. 
However, in such large lesions with infiltrative tumor within 
the surrounding structures, an aggressive surgical behavior 
may determine bad clinical outcomes. In such cases, a sub-
total resection of the tumors without the removal of small 
tumor tissues attached to vital neurovascular structures 
might offer a satisfactory result.
In regard to malignant lesions, the few cases presented 
here gave us a clue of their aggressive behavior indepen-
dently of the extent of the surgical resection. Even though 
some series report some degree of survival in high grade 
gliomas, only proper long-term FUs with adequate registry 
systems will offer reliable results [7, 8]. The unique grade 
II astrocytoma in our series died 3 months after delayed 
thalamic infarction following GTR. A multiple extrapineal 
posterior fossa recurrence of a glioblastoma multiforme 
(GBM) followed probable cerebrospinal fluid dissemina-
tion after GTR, and a local recurrence of a grade III glioma 
appeared few months after GTR. It seems that genotype and 
molecular features of diffuse gliomas, such as the presence 
of H3 K27M-mutant, IDH wildtype, O-6-methylguanine-
DNA methyltransferase methylation, or -according to last 
research- even excitatory synapse between neurons and can-
cer cells, are more important aspects to take into account 
for analyzing survival rates in diffuse pineal region gliomas 
[21–25]. Stowe et al. performed a comprehensive review of 
pineal region GBM and surprisingly discovered that GBM 
patients who received radiochemotherapy without tumor 
resection had better survivals than GBM patients who 
underwent resection and radiochemotherapy [23]. Obvi-
ously, more evidences are required to clarify in detail these 
findings.
The modest number of cases presented in this study is a 
clear limitation to generalize our results, particularly for high 
grade diffuse gliomas. Thus, Further studies with a bigger 
sample of patients are required to validate our hypothesis.
Conclusion
In this small retrospective series, differences in the extent 
of resection between GTR and incomplete resection mostly 
represented by the STR, did not consistently affect the sur-
vival outcomes of gliomas of the pineal region. While dif-
fuse gliomas carry a very poor prognosis. PA and low grade 
ependymomas have excellent long-term survival outcomes 
independently of the extent of resection.
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